Search results
Jul 18, 2024 · In1996, Martine Rothblatt’s six-year-old daughter was diagnosed with pulmonary arterial hypertension, a rare lung and heart disease without a cure. Undeterred, Rothblatt, a cofounder of Sirius ...
1 day ago · Martine Rothblatt, the Chairperson and CEO of United Therapeutics (NASDAQ: UTHR) Corporation (NASDAQ:UTHR), recently sold a substantial amount of company stock, according to the latest SEC filings. The transactions, which occurred on July 23 and 24, involved the sale of United Therapeutics shares at prices ranging from $331.7005 to $337.33 ...
Jul 3, 2024 · Discover how Martine Rothblatt, the visionary founder of United Therapeutics, revolutionized the biotech industry with her innovative approaches and relentless pursuit of medical...
4 days ago · En 1996, Martine Rothblatt apprend que sa fille de six ans est atteinte d’hypertension artérielle pulmonaire, une maladie pulmonaire et cardiaque rare qui n’a pas de remède. Sans se décourager, Martine Rothblatt, cofondatrice de Sirius Satellite Radio, a lancé sa propre entreprise de biotechnologie dans le but de trouver le remède.
Jul 15, 2024 · Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp, sold 7,200 shares of common stock over two days, with transactions dated 2024-07-11 and 2024-07-12. The sales were executed at weighted average prices ranging from $321.1773 to $329.794, totaling $2,343,345.
Jul 5, 2024 · United Therapeutics (NASDAQ: UTHR) Corporation (NASDAQ:UTHR) CEO Martine Rothblatt has recently sold a significant portion of her stock in the company, totaling over $2.2 million. The...
Jul 13, 2024 · United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the firm’s stock in a transaction dated Wednesday, July 10th. The shares were sold at an average price of $326.35, for a total value of $1,174,860.00.
